Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: CRISPR Therapeutics AG, 3 years.
CRISPR Therapeutics AG
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
CRISPR Therapeutics AG June 4, 202695.2%
-
CRISPR Therapeutics AG June 5, 202596.2%
-
CRISPR Therapeutics AG May 30, 202480.1%
-
CRISPR Therapeutics AG June 8, 202393.2%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 26, 2025 | CRISPR Therapeutics AG | Open-market purchase | +7,000 | $44.85 | $313,950 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.